Clinical Trial Update: Phase II Study of PX-12 in Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

This is a trial update indicating the Phase II trial of PX-12 in advanced pancreatic cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neoplasms

Drugs mentioned

• PX-12 (PX-12)

Snippet

Sponsor: Cascadian Therapeutics Inc. | Conditions: Pancreatic Neoplasms | Phase 2 | Status: TERMINATED